Areas Without Adequate Human Evidence Cardiovascular safety Neurological and psychiatric effects Liver and kidney safety Effects on blood glucose in humans Effects on methylation pathways Genotoxicity Carcinogenicity Reproductive and developmental toxicity Use during pregnancy or breastfeeding Interactions with prescription medicines Interactions with supplements or research compounds Long-term exposure Product-Quality Risks Incorrect quinolinium compound Wrong substitution position Incorrect counterion Incorrect active-content calculation Residual starting materials Residual solvents Degradation products Heavy-metal or inorganic contamination Mismatched certificate of analysis Uncontrolled storage and transport Absence of published harm is not proof of safety A compound without routine regulated human exposure may generate very few formal safety reports simply because there is no organised pharmacovigilance system

Indian research shows that symmetrical polyarthritis is the most common pattern, accounting for 58% of cases, while asymmetric oligoarthritis appears in 21%
Individual responses vary based on age, baseline skin quality, dosing protocol, and consistency of treatment
The published policy permits cancellation and limited refunds in specific circumstances: a full refund if a medical provider disqualifies you before medication is ordered, but no refund once it's ordered, and rendered clinical services are non-refundable regardless
[2] Some individuals do experience gastrointestinal side effects when taking B12 supplements, particularly when first beginning supplementation
Biological Sex Women typically achieve higher BAC levels than men at equivalent consumption amounts due to lower average body water percentage, higher average body fat percentage, and lower gastric ADH enzyme activity